• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Protein S Deficiency with Recurrent Thromboembolism after Splenectomy in a Patient with Hemoglobin H Disease.

作者信息

Wu Yi, Yin Xiaolin, Yang Kun

机构信息

Department of Hematology, Guangan People's Hospital, Guangan, China.

Department of Hematology, The 923rd Hospital of the Joint Logistics Support Force of the People's Liberation Army, Nanning, China.

出版信息

Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024017. doi: 10.4084/MJHID.2024.017. eCollection 2024.

DOI:10.4084/MJHID.2024.017
PMID:38468830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10927212/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f6/10927212/bfaada10ccbf/mjhid-16-1-e2024017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f6/10927212/bfaada10ccbf/mjhid-16-1-e2024017f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36f6/10927212/bfaada10ccbf/mjhid-16-1-e2024017f1.jpg

相似文献

1
Protein S Deficiency with Recurrent Thromboembolism after Splenectomy in a Patient with Hemoglobin H Disease.血红蛋白H病患者脾切除术后复发性血栓栓塞伴蛋白S缺乏
Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024017. doi: 10.4084/MJHID.2024.017. eCollection 2024.
2
Analysis of the genetic variants associated with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy: A case report.脾切除术后血红蛋白H病患者复发性血栓栓塞相关基因变异分析：一例报告
Biomed Rep. 2016 Jul;5(1):23-26. doi: 10.3892/br.2016.674. Epub 2016 May 12.
3
Recurrent thrombophlebitis due to protein C deficiency after splenectomy for immune thrombocytopenic purpura.
Acta Haematol. 1989;82(3):154-5. doi: 10.1159/000205366.
4
Recurrent thromboembolism after splenectomy in a patient with complex hemoglobin disease: a case report.一名患有复杂血红蛋白病的患者脾切除术后复发性血栓栓塞：病例报告
Rev Bras Hematol Hemoter. 2017 Oct-Dec;39(4):354-356. doi: 10.1016/j.bjhh.2017.04.006. Epub 2017 May 17.
5
Hypercoagulable state as demonstrated by thromboelastometry in hemoglobin E/beta-thalassemia patients: Association with clinical severity and splenectomy status.血栓弹力描记术显示血红蛋白 E/β-地中海贫血患者存在高凝状态：与临床严重程度和脾切除术状态的关系。
Thromb Res. 2016 Apr;140:125-131. doi: 10.1016/j.thromres.2016.02.014. Epub 2016 Feb 15.
6
Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency.
Am J Hematol. 2001 Jul;67(3):197-9. doi: 10.1002/ajh.1107.
7
Risk factors for thromboembolism and pulmonary artery hypertension following splenectomy in children with hereditary spherocytosis.遗传性球形红细胞增多症患儿脾切除术后血栓栓塞和肺动脉高压的危险因素。
Pediatr Blood Cancer. 2014 Jan;61(1):29-33. doi: 10.1002/pbc.24766. Epub 2013 Sep 13.
8
Sideroblastic anemia with splenic abscess and fatal thromboemboli after splenectomy.
Ann Intern Med. 1975 Nov;83(5):661-3. doi: 10.7326/0003-4819-83-5-661.
9
[Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].[凝血因子XII（哈格曼因子）缺乏：血栓栓塞形成的危险因素。复发性静脉或动脉血栓栓塞及心肌梗死后患者中凝血因子XII缺乏的发生率]
Wien Med Wochenschr. 1993;143(2):43-50.
10
Blood coagulation and platelet profiles in persistent post-splenectomy thrombocytosis. The relationship to thromboembolism.脾切除术后持续性血小板增多症的凝血和血小板指标。与血栓栓塞的关系。
Biomed Pharmacother. 1985;39(6):264-71.

本文引用的文献

1
Hemoglobin H Disease and Growth: A Comparative Study of DHbH and NDHbH Patients.血红蛋白H病与生长：DHbH和NDHbH患者的比较研究
Mediterr J Hematol Infect Dis. 2023 Sep 1;15(1):e2023045. doi: 10.4084/MJHID.2023.045. eCollection 2023.
2
American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing.美国血液学会 2023 年静脉血栓栓塞症管理指南：血栓形成倾向检测。
Blood Adv. 2023 Nov 28;7(22):7101-7138. doi: 10.1182/bloodadvances.2023010177.
3
Protein S: function, regulation, and clinical perspectives.
蛋白质 S：功能、调节及临床观点。
Curr Opin Hematol. 2021 Sep 1;28(5):339-344. doi: 10.1097/MOH.0000000000000663.
4
Clinical Manifestation and Mutation Spectrum of 53 Unrelated Pedigrees with Protein S Deficiency in China.中国 53 个无血缘关系的蛋白 S 缺乏症家系的临床表现和突变谱。
Thromb Haemost. 2019 Mar;119(3):449-460. doi: 10.1055/s-0038-1677031. Epub 2019 Jan 22.
5
Elevations of Thrombotic Biomarkers in Hemoglobin H Disease.血红蛋白H病中血栓形成生物标志物的升高
Acta Haematol. 2018;139(1):47-51. doi: 10.1159/000486157. Epub 2018 Jan 18.
6
Thalassemia and the hypercoagulable state.地中海贫血与高凝状态。
Thromb Res. 2013;132(6):637-41. doi: 10.1016/j.thromres.2013.09.029. Epub 2013 Sep 27.
7
Hypercoagulability in β-thalassemia: a status quo.β-地中海贫血中的高凝状态：现状。
Expert Rev Hematol. 2012 Oct;5(5):505-11; quiz 512. doi: 10.1586/ehm.12.42.
8
Clinical and genetic features of protein C deficiency in 23 unrelated Chinese patients.23 例非相关中国人蛋白 C 缺乏症的临床和遗传学特征。
Blood Cells Mol Dis. 2013 Jan;50(1):53-8. doi: 10.1016/j.bcmd.2012.08.004. Epub 2012 Aug 27.
9
Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese population.对蛋白 C 缺乏症的遗传背景分析显示，在中国人群中与静脉血栓形成相关的一种反复出现的突变。
PLoS One. 2012;7(4):e35773. doi: 10.1371/journal.pone.0035773. Epub 2012 Apr 24.
10
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.地中海贫血中间型管理实践概述，旨在降低流行地区的并发症发生率：OPTIMAL CARE 研究。
Blood. 2010 Mar 11;115(10):1886-92. doi: 10.1182/blood-2009-09-243154. Epub 2009 Dec 23.